New York University wants to expand our minds — but in a trippy new way.
NYU Langone Health’s Department of Psychiatry plans to establish a Center for Psychedelic Medicine, a hallucinatory hub that will support research on treating addiction, chronic pain, opioid addiction and “existential distress” — among other physical and emotional maladies — using psychedelics.
The program, announced Wednesday, will also be the home base for NYU’s new Psychedelic Medicine Research Training Program, which will attempt to make psychedelic medicine more mainstream and increase the number of experts in the field.
The new facility is backed by $10 million from donors, including Dr. Bronner’s soaps and psychedelic medicine company MindMed.
The center is being created to “ensure that the momentum created by the modern psychedelic renaissance is sustained,” according to NYU psychiatry professor Michael P. Bogenschutz, who will be the center’s director.